TgPRELID, a Mitochondrial Protein Linked to Multidrug Resistance in the Parasite <named-content content-type="genus-species">Toxoplasma gondii</named-content>

ABSTRACT New drugs to control infection with the protozoan parasite Toxoplasma gondii are needed as current treatments exert toxic side effects on patients. Approaches to develop novel compounds for drug development include screening of compound libraries and targeted inhibition of essential cellula...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Victoria Jeffers, Edwin T. Kamau, Ananth R. Srinivasan, Jonathan Harper, Preethi Sankaran, Sarah E. Post, Joseph M. Varberg, William J. Sullivan, Jon P. Boyle
Format: article
Langue:EN
Publié: American Society for Microbiology 2017
Sujets:
Accès en ligne:https://doaj.org/article/b3da351a960c48d3b9fbeae40b5dad3a
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!